Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/05/2010WO2010085845A1 Cancer therapy and/or diagnosis
08/05/2010WO2010066931A4 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
08/05/2010WO2010066046A8 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
08/05/2010WO2010063470A3 Methods for preventing or reducing colon carcinogenesis
08/05/2010WO2010059969A3 Use of anti-vegf antibody in combination with chemtherapy for treating breast cancer
08/05/2010WO2010059239A3 Lactate salt of 4-(6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
08/05/2010WO2010042867A3 Activators of human pyruvate kinase
08/05/2010WO2010033196A3 Simplified one-pot synthesis of [18f]sfb for radiolabeling
08/05/2010WO2010031708A3 Ortho-aminoanilides for the treatment of cancer
08/05/2010WO2010028093A3 Use of a truncated elf-5a1 polynucleotide to induce apoptosis in cancer cells
08/05/2010WO2010014784A3 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
08/05/2010WO2010012912A3 Use of a soluble form of hla-g in the treatment of abnormal b-lymphocyte proliferation
08/05/2010WO2010001169A3 Chemical compounds 251
08/05/2010WO2009152228A9 Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen
08/05/2010WO2009052617A9 Treatment regime for proliferative disorders
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197784 Novel curcumin analogues and uses thereof
08/05/2010US20100197782 Therapeutic agent for virus-associated malignancy
08/05/2010US20100197780 Compounds extracted from palm oil mill effluent for the treatment of cancer, compositions thereof and methods therewith
08/05/2010US20100197779 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
08/05/2010US20100197776 Direct dissolution of docetaxel in a solvent in polysorbate 80
08/05/2010US20100197774 MicroRNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS
08/05/2010US20100197769 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd)
08/05/2010US20100197767 Nucleic acid construct systems capable of daignosing or treating a cell state
08/05/2010US20100197766 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and Uses Thereof in the Treatment of Cancer
08/05/2010US20100197765 Method for promoting the expression of p53, and p53 expression promoter for use in the method
08/05/2010US20100197757 Oxindoles as kinase inhibitors
08/05/2010US20100197754 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
08/05/2010US20100197746 Synthesis of epothilones, intermediates thereto and analogues thereof
08/05/2010US20100197745 Gamma-glutamyl transpeptidase inhibitors and methods of use
08/05/2010US20100197744 Organic Compounds
08/05/2010US20100197725 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
08/05/2010US20100197722 Treatment for basal cell carcinoma
08/05/2010US20100197718 Treatment of pediatric tumors
08/05/2010US20100197711 Benzothiazole compounds
08/05/2010US20100197695 Antitumoral derivatives of et-743
08/05/2010US20100197690 Pyrimidinyl Pyridazinone Derivatives
08/05/2010US20100197686 Therapeutic compounds
08/05/2010US20100197682 Organic Compounds
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197671 Phenyl amino pyrimidine compounds and uses thereof
08/05/2010US20100197668 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
08/05/2010US20100197664 Novel b1-antagonists
08/05/2010US20100197657 2-aryl or heteroaryl indole derivatives
08/05/2010US20100197654 Triazine kinase inhibitors
08/05/2010US20100197645 Thioamide Derivatives as Progesterone Receptor Modulators
08/05/2010US20100197634 Inhibitors of janus kinases
08/05/2010US20100197627 Pancreatic cancer treatment
08/05/2010US20100197625 Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders
08/05/2010US20100197622 Non-Peptide Macrocyclic Histone Deacetylase (HDAC) Inhibitors and Methods of Making and Using Thereof
08/05/2010US20100197619 Cyclin-dependent protein kinases inhibitors of scutellaria flavonoid organic amine derivatives, synthesis and use thereof
08/05/2010US20100197618 Extract of rehmannia glutinasa libosch for reducing blood sugar, reducing blood fat, treating leukemia, and preparation method uses thereof
08/05/2010US20100197612 Composition and Methods for the Treatment of Cancer
08/05/2010US20100197608 Use of melanotrophin-potentiating factor as a therapeutic agent
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
08/05/2010US20100197604 Use of peptide as a therapeutic agent
08/05/2010US20100197603 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
08/05/2010US20100197602 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection
08/05/2010US20100197601 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection
08/05/2010US20100197600 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent
08/05/2010US20100197599 Use of a peptide as a therapeutic agent
08/05/2010US20100197595 Treatment of melanoma with alpha thymosin peptides
08/05/2010US20100197593 Modulators of the ABC Transporter Family and Methods for their Use
08/05/2010US20100197589 Modified growth hormone polypeptides
08/05/2010US20100197588 Use of a peptide as a therapeutic agent
08/05/2010US20100197587 Use of a peptide as a therapeutic agent
08/05/2010US20100197585 Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agent
08/05/2010US20100197584 Use of curcumin to block brain tumor formation in mice
08/05/2010US20100197572 Use of somatostatin-14 as a therapeutic agent
08/05/2010US20100197570 Cyclodepsipeptides with Antineoplastic Activity and Methods of Using to Inhibit Cancer and Microbial Growth
08/05/2010US20100197015 Human liver progenitors
08/05/2010US20100196989 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
08/05/2010US20100196891 IBC-1 (Invasive Breast Cancer-1), a Putative Oncogene Amplified in Breast Cancer
08/05/2010US20100196511 Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
08/05/2010US20100196509 Methods for Diagnosis and Treatment of Endometrial Cancer
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196492 Electrostatic coating of particles for drug delivery
08/05/2010US20100196490 Compositions and methods of delivery of pharmacological agents
08/05/2010US20100196468 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
08/05/2010US20100196465 Stable pharmaceutical composition of a water-soluble vinorelbine salt
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
08/05/2010US20100196450 Targeting pax2 for the induction of defbi-mediated tumor immunity and cancer therapy
08/05/2010US20100196443 Use of cordyceps species or extract thereof in the egg production
08/05/2010US20100196426 Use of microvesicles in diagnosis and prognosis of medical diseases and conditions
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/05/2010US20100196417 Compositions comprising a b subunit of shiga toxin and a means stimulating nkt cells
08/05/2010US20100196412 Homogeneous vaccine composition for the tumor treatment and its obtaining method
08/05/2010US20100196403 Antibody conjugates for circumventing multi-drug resistance
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196398 Targeted binding agents directed to cd105 and uses thereof
08/05/2010US20100196395 Anti-igf antibodies
08/05/2010US20100196394 Anti-cancer vaccine composition
08/05/2010US20100196393 Modulation of blood brain barrier protein expression
08/05/2010US20100196392 Anti-system asc amino acid transporter 2 (asct2) antibody
1 ... 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 ... 2211